These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 27327504)
21. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation. Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034 [TBL] [Abstract][Full Text] [Related]
23. N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome. Khan SQ; Narayan H; Ng KH; Dhillon OS; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL Clin Sci (Lond); 2009 Jun; 117(1):31-9. PubMed ID: 19170658 [TBL] [Abstract][Full Text] [Related]
24. Optimization of GRACE Risk Stratification by N-Terminal Pro-B-type Natriuretic Peptide Combined With D-Dimer in Patients With Non-ST-Elevation Myocardial Infarction. Lu PJ; Gong XW; Liu Y; Tian FS; Zhang WJ; Liu YW; Yao ZH; Wang JX; Han P; Yang YN; Cui Z; Gao J Am J Cardiol; 2021 Feb; 140():13-19. PubMed ID: 33159905 [TBL] [Abstract][Full Text] [Related]
25. Improved predictive value of GRACE risk score combined with platelet reactivity for 1-year cardiovascular risk in patients with acute coronary syndrome who underwent coronary stent implantation. Li S; Liu H; Liu J; Wang H Platelets; 2016 Nov; 27(7):650-657. PubMed ID: 27809713 [TBL] [Abstract][Full Text] [Related]
26. Addition of B-type natriuretic peptide to the GRACE score to predict outcome in acute coronary syndrome: a retrospective (development) and prospective (validation) cohort-based study. Guidez T; Maréchaux S; Pinçon C; Lamour H; Barrailler S; Decourcelle V; Braun S; Bouabdallaoui N; Bauchart JJ; Auffray JL; Hennache B; Juthier F; Vincentelli A; Asseman P; Van Belle E; Ennezat PV Emerg Med J; 2012 Apr; 29(4):274-9. PubMed ID: 21521903 [TBL] [Abstract][Full Text] [Related]
27. The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide. Meune C; Drexler B; Haaf P; Reichlin T; Reiter M; Meissner J; Twerenbold R; Stelzig C; Freese M; Winkler K; Mueller C Heart; 2011 Sep; 97(18):1479-83. PubMed ID: 21444339 [TBL] [Abstract][Full Text] [Related]
28. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis. Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908 [TBL] [Abstract][Full Text] [Related]
29. A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department. Bhardwaj A; Truong QA; Peacock WF; Yeo KT; Storrow A; Thomas S; Curtis KM; Foote RS; Lee HK; Miller KF; Januzzi JL Am Heart J; 2011 Aug; 162(2):276-282.e1. PubMed ID: 21835288 [TBL] [Abstract][Full Text] [Related]
30. [Predictive value of GRACE discharge score for long-term out-of-hospital death in acute coronary syndrome after percutaneous coronary intervention]. Zhao XY; Li JX; Tang XF; Xu JJ; Song Y; Wang HH; Xu LJ; Chen J; Zhang Y; Song L; Gao LJ; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(7):496-501. PubMed ID: 29495217 [No Abstract] [Full Text] [Related]
31. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score. Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283 [TBL] [Abstract][Full Text] [Related]
32. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657 [TBL] [Abstract][Full Text] [Related]
33. Predictive value of the novel risk score BETTER (BiomarkErs and compuTed Tomography scorE on Risk stratification) for patients with unstable angina. Xia Y; Xia Y; Xu K; Ma Y; Pan D; Xu T; Lu L; Li D Herz; 2015 Mar; 40 Suppl 1():43-50. PubMed ID: 25171840 [TBL] [Abstract][Full Text] [Related]
34. Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals. Reiser H; Klingenberg R; Hof D; Cooksley-Decasper S; Fuchs N; Akhmedov A; Zoller S; Marques-Vidal P; Marti Soler H; Heg D; Landmesser U; Rodondi N; Mach F; Windecker S; Vollenweider P; Matter CM; Lüscher TF; von Eckardstein A; Gawinecka J Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1872-9. PubMed ID: 26069234 [TBL] [Abstract][Full Text] [Related]
35. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP. Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364 [TBL] [Abstract][Full Text] [Related]
36. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
37. Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) study. Glaser R; Peacock WF; Wu AH; Muller R; Möckel M; Apple FS Am J Cardiol; 2011 Mar; 107(6):821-6. PubMed ID: 21247525 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249 [TBL] [Abstract][Full Text] [Related]
39. A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score. Mehta SR; Eikelboom JW; Rao-Melacini P; Weitz JI; Anand SS; Pare G; Budaj A; Pogue J; Fox KA; Yusuf S Can J Cardiol; 2016 Nov; 32(11):1332-1339. PubMed ID: 27062239 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]